Loading company…
Nuoning Biology is a Beijing biotechnology company developing polymer antibody-drug conjugates for cancer treatment.
Based in Beijing, China and established in 2015, Nuoning Biology researches and develops antibody-drug conjugates (ADCs) using its polymer conjugation and third-generation ADC technology. Its products are aimed at lung, breast, cervical, ovarian and prostate cancers. In 2021 the company raised RMB 35 million in strategic investment from Huadong Medicine Co.,Ltd., and it generates revenue by selling its polymer antibody-drug conjugates to customers.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in